Home / GILEAD SCIENCES, INC. (GILD)
Stock Analysis
GILEAD SCIENCES, INC. (GILD)
GILD
GILD · Healthcare • Biotech
127.23 +2.36%
52W Range Position
43%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-06-16 20:46 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Moderate / Strong
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
128.53
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving GILD?
📈 Technical recovery is improving
Momentum is Neutral. Watch 128.53 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 10
Watch Level
133.94
RSI(14)
45.3
Price Chart
GILD · WOI overlay chart
Open Full Workspace
Business Lens
Long-term structure remains supportive
Revenue Growth
Moderate
Profitability
Strong
Cash Flow
Pressured
Balance Sheet
Manageable
💵 Revenue
6.96B
📈 Net Income
2.02B
🧮 EPS (Basic)
0.81
🏢 Company
GILEAD SCIENCES, INC.
🏷 Sector
Healthcare
🧩 Industry
Biotech
Note: This is an algorithmic technical snapshot, not financial advice.